Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement.
The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement.
Oil futures are on track for weekly gains, taking back some of the ground lost last week as fears of a broader Middle East war...
The cryptocurrency industry’s spending on Washington lobbying rose to a fresh record last year, while it’s started out 2024 with more sizable spending to influence...
The U.S. stock market’s climb this year probably has stalled for the rest of 2024, even as investors remain optimistic that companies stand to benefit...
While the spring sales typically have more than a dozen works offered for more than $30 million each, this year there are just a few.
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability...
A slew of commentary from the Bank of England and a better-than-expected economic growth number have left traders and investors scrambling to refine their bets.
While the spring sales typically have more than a dozen works offered for more than $30 million each, this year there are just a few.
Toncoin price surged by more than 13% amid news around new project Notcoin (NOT). Binance and OKX among exchanges to list NOT token. Bitbot could...